Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
QuintilesIMS
Colorcon
Argus Health
Fuji
Merck
McKinsey
Farmers Insurance

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,501,818

« Back to Dashboard

Summary for Patent: 8,501,818
Title:Stabilized compositions of alkylating agents and methods of using same
Abstract: Provided are stable compositions comprising alkylating agents, including nitrogen mustards, that are suitable for topical use, and methods for treating skin disorders comprising topically administering the compositions.
Inventor(s): Alonso; Robert (Rye, NH), Stogniew; Martin (Blue Bell, PA), Crooks; Peter A. (Nicholasville, KY), Pimley; Mark A. (Westchester, PA), Worthen; David R. (Wakefield, RI)
Assignee: Ceptaris Therapeutics, Inc. (Malvern, PA)
Application Number:12/687,605
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 8,501,818

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Actelion Pharms Ltd VALCHLOR mechlorethamine hydrochloride GEL;TOPICAL 202317-001 Aug 23, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,501,818

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,664,278 Stabilized compositions of volatile alkylating agents and methods of using thereof ➤ Try a Free Trial
7,872,050 Stabilized compositions of volatile alkylating agents and methods of using thereof ➤ Try a Free Trial
8,450,375 Stabilized compositions of volatile alkylating agents and methods of using thereof ➤ Try a Free Trial
2,010,029,783 ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,501,818

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 1858864 ➤ Try a Free Trial
Portugal 1858864 ➤ Try a Free Trial
Poland 1858864 ➤ Try a Free Trial
New Zealand 599001 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fuji
AstraZeneca
Dow
Express Scripts
Fish and Richardson
McKinsey
Medtronic
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.